{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:06:41Z","timestamp":1791205601136,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["R01MD018085"],"award-info":[{"award-number":["R01MD018085"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-27526-7","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:36:40Z","timestamp":1776926200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["\u201cWith a little help from my friends\u201d - collaborating with community experts to improve sampling and obtain a high response rate for a statewide naloxone availability survey"],"prefix":"10.1186","volume":"26","author":[{"given":"Caroline","family":"Shubel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Marley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Isac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Bordeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delesha","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayla","family":"Ostrach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"27526_CR1","unstructured":"Drug Overdose Deaths. Facts and Figures [Internet]. [cited 2025 Oct 14]. Available from: https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"key":"27526_CR2","unstructured":"NCDHHS Injury & Violence Prevention. Opioid and Substance Use Action Plan Data Dashboard [Internet]. n.d. [cited 2023 Jan 30]. Available from: https:\/\/www.ncdhhs.gov\/opioid-and-substance-use-action-plan-data-dashboard"},{"key":"27526_CR3","unstructured":"NCDHHS. North Carolina Reports 22% Increase In Overdose Deaths. Available from: https:\/\/www.ncdhhs.gov\/news\/press-releases\/2023\/02\/21\/north-carolina-reports-22-increase-overdose-deaths. Cited 17 Apr 2024."},{"key":"27526_CR4","unstructured":"Carroll JJ, Green TC, Noonan RK. Evidence-based strategies for preventing opioid overdose: what\u2019s working in the United States. Natl Cent Inj Prev Control Cent Dis Control Prev; 2018."},{"issue":"33","key":"27526_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15585\/mmwr.mm6933a2","volume":"69","author":"BH Lambdin","year":"2020","unstructured":"Lambdin BH, Bluthenthal RN, Wenger LD, Wheeler E, Garner B, Lakosky P, et al. Overdose Education and Naloxone Distribution Within Syringe Service Programs \u2014 United States, 2019. Morb Mortal Wkly Rep. 2020;69(33):1117\u201321.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"27526_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/09687637.2014.981509","volume":"22","author":"SM Bird","year":"2015","unstructured":"Bird SM, Parmar MK, Strang J. Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland\u2019s public health policy evaluation, and a new measure to assess impact. Drugs Educ Prev Policy. 2015;22(1):66\u201376.","journal-title":"Drugs Educ Prev Policy"},{"issue":"1","key":"27526_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","volume":"158","author":"PO Coffin","year":"2013","unstructured":"Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1\u20139.","journal-title":"Ann Intern Med"},{"key":"27526_CR8","doi-asserted-by":"crossref","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177\u201387.","DOI":"10.1111\/add.13326"},{"key":"27526_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","volume":"46","author":"N Fairbairn","year":"2017","unstructured":"Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172\u20139.","journal-title":"Int J Drug Policy"},{"key":"27526_CR10","unstructured":"Connolly B, Bluestein JPEW, Charitable T. Improved Naloxone Access Can Reduce Opioid Overdose Deaths. 2020. Available from: https:\/\/pew.org\/2HcTXYA. Cited 25 Oct 2021."},{"key":"27526_CR11","unstructured":"Doe-Simkins M, Davis CS, Bazron B, Frankel S. Naloxone Saturation: An Overview and Models for Success [Internet]. RxSummit;, Atlanta GA. Available from: https:\/\/www.eventscribe.net\/2023\/RxSummit\/agenda.asp?BCFO=&pfp=FullSchedule&fa=&fb=&fc=&fd=&all=1&mode=."},{"key":"27526_CR12","volume-title":"Review of Literature on Naloxone Distribution Strategies: Impact on Overdose Deaths and Contextual Factors","author":"E Major","year":"2020","unstructured":"Major E, Ostrach B. Review of Literature on Naloxone Distribution Strategies: Impact on Overdose Deaths and Contextual Factors. Asheville, NC: Oct; 2020."},{"issue":"3","key":"27526_CR13","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.japh.2025.102357","volume":"65","author":"E Gravlee","year":"2025","unstructured":"Gravlee E, Wartman C, Rosenthal M. Over-the-counter naloxone availability: Insights from rural community pharmacists in the Southern United States. J Am Pharm Assoc. 2025;65(3):102357.","journal-title":"J Am Pharm Assoc"},{"key":"27526_CR14","doi-asserted-by":"publisher","first-page":"112545","DOI":"10.1016\/j.drugalcdep.2024.112545","volume":"267","author":"DM Carpenter","year":"2025","unstructured":"Carpenter DM, Marley GT, Annis IE, Delamater P, Egan KL. Over-the-counter naloxone availability at North Carolina community pharmacies: A secret shopper study. Drug Alcohol Depend. 2025;267:112545.","journal-title":"Drug Alcohol Depend"},{"key":"27526_CR15","doi-asserted-by":"crossref","unstructured":"Marley GT, Annis IE, Egan KL, Delamater P, Carpenter DM. Naloxone Availability and Cost After Transition to an Over-the-Counter Product. JAMA Health Forum. 2024;26(7):e241920.","DOI":"10.1001\/jamahealthforum.2024.1920"},{"key":"27526_CR16","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.","journal-title":"BMJ"},{"key":"27526_CR17","doi-asserted-by":"publisher","first-page":"102536","DOI":"10.1016\/j.drugpo.2019.07.031","volume":"75","author":"T Townsend","year":"2020","unstructured":"Townsend T, Blostein F, Doan T, Madson-Olson S, Galecki P, Hutton DW. Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. Int J Drug Policy. 2020;75:102536.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"27526_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/dar.12551","volume":"37","author":"SM Bagley","year":"2018","unstructured":"Bagley SM, Forman LS, Ruiz S, Cranston K, Walley AY. Expanding access to naloxone for family members: The Massachusetts experience. Drug Alcohol Rev. 2018;37(4):480\u20136.","journal-title":"Drug Alcohol Rev"},{"key":"27526_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","volume":"55","author":"C Keane","year":"2018","unstructured":"Keane C, Egan JE, Hawk M. Effects of naloxone distribution to likely bystanders: Results of an agent-based model. Int J Drug Policy. 2018;55:61\u20139.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"27526_CR20","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","volume":"102","author":"M Davoli","year":"2007","unstructured":"Davoli M, Bargagli AM, Perucci CA, Schifano P, Belleudi V, Hickman M, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007;102(12):1954\u20139.","journal-title":"Addiction"},{"key":"27526_CR21","unstructured":"Vera Institute. Overdose Deaths and Jail Incarceration - Case study: North Carolina. 2020 . Available from: https:\/\/www.vera.org\/publications\/overdose-deaths-and-jail-incarceration\/case-study-north-carolina. Cited 10 Aug 2021."},{"issue":"8","key":"27526_CR22","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/add.13803","volume":"112","author":"A Bukten","year":"2017","unstructured":"Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T. High risk of overdose death following release from prison: variations in mortality during a 15-year observation period: High risk of overdose following release. Addiction. 2017;112(8):1432\u20139.","journal-title":"Addiction"},{"issue":"5","key":"27526_CR23","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/add.13265","volume":"111","author":"SM Bird","year":"2016","unstructured":"Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: a before (2006\u201310) versus after (2011\u201313) comparison. Addiction. 2016;111(5):883\u201391.","journal-title":"Addiction"},{"issue":"3","key":"27526_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/jamainternmed.2013.1604","volume":"173","author":"TP Baggett","year":"2013","unstructured":"Baggett TP, Hwang SW, O\u2019Connell JJ, Porneala BC, Stringfellow EJ, Orav EJ, et al. Mortality Among Homeless Adults in Boston: Shifts in Causes of Death Over a 15-Year Period. JAMA Intern Med. 2013;173(3):189.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"27526_CR25","doi-asserted-by":"publisher","first-page":"e1003759","DOI":"10.1371\/journal.pmed.1003759","volume":"18","author":"D Lewer","year":"2021","unstructured":"Lewer D, Eastwood B, White M, Brothers TD, McCusker M, Copeland C, et al. Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study. PLOS Med. 2021;18(10):e1003759.","journal-title":"PLOS Med"},{"issue":"11","key":"27526_CR26","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1007\/s11606-022-08014-1","volume":"38","author":"JR Lyden","year":"2023","unstructured":"Lyden JR, Xu S, Narwaney KJ, Glanz JM, Binswanger IA. Opioid Overdose Risk Following Hospital Discharge Among Individuals Prescribed Long-Term Opioid Therapy: a Risk Interval Analysis. J Gen Intern Med. 2023;38(11):2560\u20137.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"27526_CR27","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","volume":"108","author":"SI Ranapurwala","year":"2018","unstructured":"Ranapurwala SI, Shanahan ME, Alexandridis AA, Proescholdbell SK, Naumann RB, Edwards D Jr, et al. Opioid overdose mortality among former North Carolina inmates: 2000\u20132015. Am J Public Health. 2018;108(9):1207\u201313. https:\/\/doi.org\/10.2105\/AJPH.2018.304514.","journal-title":"Am J Public Health"},{"issue":"6","key":"27526_CR28","first-page":"101","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC). Community-based opioid overdose prevention programs providing naloxone - United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(6):101\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"27526_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12954-023-00755-4","volume":"20","author":"BH Lambdin","year":"2023","unstructured":"Lambdin BH, Wenger L, Bluthenthal R, Bartholomew TS, Tookes HE, LaKosky P, et al. How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study. Harm Reduct J. 2023;20(1):26.","journal-title":"Harm Reduct J"},{"key":"27526_CR30","unstructured":"NCDHHS. NC Safer Syringe Initiative Annual Report, 2020\u20132021 [Internet]. www.ncdhhs.gov\/opioids; 2021 Nov. Available from: https:\/\/www.ncdhhs.gov\/media\/13767\/download?attachment"},{"issue":"3","key":"27526_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cid\/cix333","volume":"65","author":"L Canary","year":"2017","unstructured":"Canary L, Hariri S, Campbell C, Young R, Whitcomb J, Kaufman H, et al. Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States. Clin Infect Dis. 2017;65(3):514\u20137.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"27526_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/jrh.12698","volume":"39","author":"DM Carpenter","year":"2023","unstructured":"Carpenter DM, Zule WA, Hennessy CM, Evon DM, Hurt CB, Ostrach B. Factors associated with perceived ease of access to syringes in Appalachian North Carolina. J Rural Health. 2023;39(1):212\u201322.","journal-title":"J Rural Health"},{"issue":"14","key":"27526_CR33","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1080\/10826084.2020.1800741","volume":"55","author":"KE Lancaster","year":"2020","unstructured":"Lancaster KE, Cooper HLF, Browning CR, Malvestutto CD, Bridges JFP, Young AM. Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs. Subst Use Misuse. 2020;55(14):2268\u201377.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"27526_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drugpo.2007.09.002","volume":"20","author":"L Simmonds","year":"2009","unstructured":"Simmonds L, Coomber R. Injecting drug users: a stigmatised and stigmatising population. Int J Drug Policy. 2009;20(2):121\u201330.","journal-title":"Int J Drug Policy"},{"key":"27526_CR35","doi-asserted-by":"publisher","first-page":"100317","DOI":"10.1016\/j.dadr.2024.100317","volume":"14","author":"EO Chung","year":"2025","unstructured":"Chung EO, Patel SV, Wenger LD, Humphrey JL, Sukasih A, Bluthenthal RN, et al. Association of safer smoking supply distribution with participant encounters and naloxone distribution from syringe services programs: Findings from the National Survey of Syringe Services Programs in the United States. Drug Alcohol Depend Rep. 2025;14:100317.","journal-title":"Drug Alcohol Depend Rep"},{"key":"27526_CR36","doi-asserted-by":"crossref","unstructured":"Ibragimov U, Cooper KE, Batty E, Ballard AM, Fadanelli M, Gross SB, et al. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky. Harm Reduct J. 2021;30(1):68.","DOI":"10.1186\/s12954-021-00518-z"},{"issue":"1","key":"27526_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12954-021-00524-1","volume":"18","author":"K Thakarar","year":"2021","unstructured":"Thakarar K, Sankar N, Murray K, Lucas FL, Burris D, Smith RP. Injections and infections: understanding syringe service program utilization in a rural state. Harm Reduct J. 2021;18(1):74.","journal-title":"Harm Reduct J"},{"key":"27526_CR38","doi-asserted-by":"publisher","unstructured":"Chung EO, Patel SV, Wenger LD, Humphrey JL, Bluthenthal RN, Tookes HE et al. Distributing Safer Smoking Pipes Increases Engagement with Harm Reduction Services in the United States: Findings from the National Survey of Syringe Services Programs. medRxiv; 2024. p. 2024.06.28.24309683. Available from: https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2024.06.28.24309683v1. Cited 25 Jul 2024.","DOI":"10.1101\/2024.06.28.24309683v1"},{"key":"27526_CR39","doi-asserted-by":"crossref","unstructured":"Tanz LJ. Routes of Drug Use Among Drug Overdose Deaths \u2014 United States, 2020\u20132022. MMWR Morb Mortal Wkly Rep. 2024;73. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/73\/wr\/mm7306a2.htm \u00a0.Cited 27 Feb 2024.","DOI":"10.15585\/mmwr.mm7306a2"},{"key":"27526_CR40","doi-asserted-by":"crossref","unstructured":"Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM et al. Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm Reduct J. 2022;19(1):79.","DOI":"10.1186\/s12954-022-00664-y"},{"key":"27526_CR41","doi-asserted-by":"crossref","unstructured":"Behrends CN, Li CS, Gibson DR. Decreased Odds of Injection Risk Behavior Associated With Direct Versus Indirect Use of Syringe Exchange: Evidence From Two California Cities. Subst Use Misuse. 2017;52(9):1145\u201353.","DOI":"10.1080\/10826084.2017.1299182"},{"key":"27526_CR42","doi-asserted-by":"crossref","unstructured":"Freiermuth CE, Ancona RM, Brown JL, Punches BE, Ryan SA, Ingram T et al. A <>Haj-Mirzaian editor 2023 Evaluation of a large-scale health department naloxone distribution program: Per capita naloxone distribution and overdose morality. PLoS ONE 18 8 e0289959.","DOI":"10.1371\/journal.pone.0289959"},{"issue":"4","key":"27526_CR43","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1080\/08897077.2019.1709250","volume":"41","author":"R Feuerstein-Simon","year":"2020","unstructured":"Feuerstein-Simon R, Lowenstein M, Sharma M, Dupuis R, Luna Marti X, Cannuscio CC. Local Health Departments and the Implementation of Evidence-Based Policies to Address Opioid Overdose Mortality. Subst Abuse. 2020;41(4):468\u201374.","journal-title":"Subst Abuse"},{"key":"27526_CR44","unstructured":"Carroll JJ, National Association of Counties (NACO). 2023. Post-Overdose Response Teams. Available from: https:\/\/www.naco.org\/resources\/opioid-solutions\/approved-strategies\/port"},{"key":"27526_CR45","doi-asserted-by":"publisher","first-page":"104164","DOI":"10.1016\/j.drugpo.2023.104164","volume":"120","author":"SD Kimmel","year":"2023","unstructured":"Kimmel SD, Xuan Z, Yan S, Lambert AM, Formica SW, Green TC, et al. Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts. Int J Drug Policy. 2023;120:104164.","journal-title":"Int J Drug Policy"},{"key":"27526_CR46","doi-asserted-by":"publisher","first-page":"104160","DOI":"10.1016\/j.drugpo.2023.104160","volume":"120","author":"JJ Carroll","year":"2023","unstructured":"Carroll JJ, Cummins ER, Formica SW, Green TC, Bagley SM, Beletsky L, et al. The police paradox: A qualitative study of post-overdose outreach program implementation through public health-public safety partnerships in Massachusetts. Int J Drug Policy. 2023;120:104160.","journal-title":"Int J Drug Policy"},{"key":"27526_CR47","doi-asserted-by":"publisher","first-page":"108499","DOI":"10.1016\/j.drugalcdep.2020.108499","volume":"219","author":"SW Formica","year":"2021","unstructured":"Formica SW, Waye KM, Benintendi AO, Yan S, Bagley SM, Beletsky L, et al. Characteristics of post-overdose public health-public safety outreach in Massachusetts. Drug Alcohol Depend. 2021;219:108499.","journal-title":"Drug Alcohol Depend"},{"key":"27526_CR48","doi-asserted-by":"publisher","first-page":"103296","DOI":"10.1016\/j.drugpo.2021.103296","volume":"97","author":"RS Bergstein","year":"2021","unstructured":"Bergstein RS, King K, Melendez-Torres GJ, Latimore AD. Refusal to accept emergency medical transport following opioid overdose, and conditions that may promote connections to care. Int J Drug Policy. 2021;97:103296.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"27526_CR49","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/emp2.12208","volume":"1","author":"T Champagne-Langabeer","year":"2020","unstructured":"Champagne-Langabeer T, Bakos\u2010Block C, Yatsco A, Langabeer JR. Emergency medical services targeting opioid user disorder: An exploration of current out\u2010of\u2010hospital post\u2010overdose interventions. J Am Coll Emerg Physicians Open. 2020;1(6):1230\u20139.","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"27526_CR50","unstructured":"Guo B, Corabian P, Yan C. Community Paramedicine: Program Characteristics and Evaluation [Internet]. Institute of Health Economics; 2017. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549088\/"},{"issue":"2","key":"27526_CR51","doi-asserted-by":"publisher","first-page":"e200117","DOI":"10.1001\/jamanetworkopen.2020.0117","volume":"3","author":"JG Katzman","year":"2020","unstructured":"Katzman JG, Takeda MY, Greenberg N, Moya Balasch M, Alchbli A, Katzman WG, et al. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program. JAMA Netw Open. 2020;3(2):e200117.","journal-title":"JAMA Netw Open"},{"key":"27526_CR52","unstructured":"Cunningham M. Vending Machines\u2014A Surprising New Use for an Old Device [Internet]. Bureau of Justice Assistance (BJA), Comprehensive Opioid, Stimulant, and Substance USe Program (COSSUP); 2023. Available from: https:\/\/www.cossapresources.org\/Content\/Documents\/Articles\/CHJ-TASC_NSA_Naloxone_Vending_Machines_June_2023.pdf"},{"key":"27526_CR53","doi-asserted-by":"publisher","unstructured":"Doe-Simkins M, Wheeler EJ, Figgatt MC, Jones TS, Bell A, Davidson PJ et al. Naloxone Buyers Club: Overlooked Critical Public Health Infrastructure for Preventing Overdose Deaths. 2021. Available from: http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2021.11.14.21266221; Cited 6 Aug 2024.","DOI":"10.1101\/2021.11.14.21266221"},{"issue":"4","key":"27526_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2105\/AJPH.2024.307583","volume":"114","author":"SN Facente","year":"2024","unstructured":"Facente SN, Humphrey JL, Akiba C, Patel SV, Wenger LD, Tookes H, et al. Funding and Delivery of Syringe Services Programs in the United States, 2022. Am J Public Health. 2024;114(4):435\u201343.","journal-title":"Am J Public Health"},{"key":"27526_CR55","doi-asserted-by":"crossref","unstructured":"Ray BR, Humphrey JL, Patel SV, Akiba CF, Bluthenthal RN, Tookes H, et al. Comparing harm reduction and overdose response services between community-based and public health department syringe service programmes using a national cross-sectional survey. Lancet Reg Health - Am. 2024;34:100757.","DOI":"10.1016\/j.lana.2024.100757"},{"key":"27526_CR56","doi-asserted-by":"crossref","unstructured":"Doe-Simkins M, Wheeler EJ. Overdose Education and Naloxone Distribution: An Evidence-Based Practice That Warrants Course Correcting. Am J Public Health. 2024;e1\u20133.","DOI":"10.2105\/AJPH.2024.307893"},{"key":"27526_CR57","unstructured":"Qualtrics NCDHHS. Survey. Available from: https:\/\/ncivpb.iad1.qualtrics.com\/jfe\/form\/SV_elAQuZ2jmAdYir4"},{"key":"27526_CR58","doi-asserted-by":"crossref","unstructured":"Ruth A, Wutich A, Bernard HR. The Handbook of Teaching Qualitative and Mixed Research Methods: A Step-by-Step Guide for Instructors [Internet]. 1st ed. London: Routledge; 2023 [cited 2026 Apr 22]. Available from: https:\/\/www.taylorfrancis.com\/books\/9781003213277.","DOI":"10.4324\/9781003213277"},{"issue":"2","key":"27526_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1017\/cts.2018.14","volume":"2","author":"AK Matthews","year":"2018","unstructured":"Matthews AK, Anderson EE, Willis M, Castillo A, Choure W. A Community Engagement Advisory Board as a strategy to improve research engagement and build institutional capacity for community-engaged research. J Clin Transl Sci. 2018;2(2):66\u201372.","journal-title":"J Clin Transl Sci"},{"key":"27526_CR60","doi-asserted-by":"crossref","unstructured":"Singer M. Knowledge for use: Anthropology and community-centered substance abuse research. Soc Sci Med. 1993 July;1(1):15\u201325.","DOI":"10.1016\/0277-9536(93)90312-R"},{"key":"27526_CR61","doi-asserted-by":"crossref","unstructured":"Kantamneni A, Winkler RL, Calvert K. Incorporating community: opportunities and challenges in community engaged research. In: Halvorsen KE, Schelly C, Handler RM, Pischke EC, Knowlton JL, editors. A Research Agenda for Environmental Management. Edward Elgar Publishing; 2019. Available from: https:\/\/www.elgaronline.com\/edcollchap\/edcoll\/9781788115186\/9781788115186.00016.xml.\u00a0\u00a0Cited 14 Oct 2025.","DOI":"10.4337\/9781788115193.00016"},{"issue":"12","key":"27526_CR62","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/jac5.1881","volume":"6","author":"LR Moczygemba","year":"2023","unstructured":"Moczygemba LR, Singh RL, Baffoe JO. Research and scholarly methods: Community-engaged research. JACCP J Am Coll Clin Pharm. 2023;6(12):1366\u201373.","journal-title":"JACCP J Am Coll Clin Pharm"},{"key":"27526_CR63","doi-asserted-by":"crossref","unstructured":"Willison DJ, McDonald M. Ethics Considerations When Involving Patients as Partners in Health Research. In: Researching Health Together: Engaging Patients and Stakeholders, From Topic Identification to Policy Change [Internet]. Thousand Oaks California: SAGE Publications, Inc.; 2021. p. 413\u201333. [cited 2026 Apr 22]. Available from: https:\/\/methods.sagepub.com\/book\/researching-health-together\/i2578.xml.","DOI":"10.4135\/9781071909539.n23"},{"key":"27526_CR64","doi-asserted-by":"crossref","unstructured":"Zimmerman E. Researching Health Together: Engaging Patients and Stakeholders, From Topic Identification to Policy Change [Internet]. Thousand Oaks: SAGE Publications, Inc.; 2021 [cited 2026 Apr 22]. Available from: https:\/\/methods.sagepub.com\/book\/researching-health-together.","DOI":"10.4135\/9781071909539"},{"issue":"1","key":"27526_CR65","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12874-016-0242-z","volume":"16","author":"MA Valerio","year":"2016","unstructured":"Valerio MA, Rodriguez N, Winkler P, Lopez J, Dennison M, Liang Y, et al. Comparing two sampling methods to engage hard-to-reach communities in research priority setting. BMC Med Res Methodol. 2016;16(1):146.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"27526_CR66","doi-asserted-by":"publisher","first-page":"469","DOI":"10.14423\/SMJ.0000000000001157","volume":"113","author":"B Ostrach","year":"2020","unstructured":"Ostrach B. Human-Centered Design for a Women\u2019s Health Screening Tool: Participant Experiences. South Med J. 2020;113(10):469\u201374.","journal-title":"South Med J"},{"issue":"1","key":"27526_CR67","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/ADM.0000000000001244","volume":"18","author":"D Carpenter","year":"2024","unstructured":"Carpenter D, Mashburn P, Viracola C, Marley G, Ostrach B. A Brief Online Training to Address Pharmacists\u2019 Willingness to Dispense Buprenorphine. J Addict Med. 2024;18(1):68\u201370.","journal-title":"J Addict Med"},{"issue":"2","key":"27526_CR68","doi-asserted-by":"publisher","first-page":"e12400","DOI":"10.1002\/trc2.12400","volume":"9","author":"A Pena-Garcia","year":"2023","unstructured":"Pena-Garcia A, Richards R, Richards M, Campbell C, Mosley H, Asper J, et al. Accelerating diversity in Alzheimer\u2019s disease research by partnering with a community advisory board. Alzheimers Dement Transl Res Clin Interv. 2023;9(2):e12400.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"1","key":"27526_CR69","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1017\/cts.2021.22","volume":"5","author":"TA Brockman","year":"2021","unstructured":"Brockman TA, Balls-Berry JE, West IW, Valdez-Soto M, Albertie ML, Stephenson NA, et al. Researchers\u2019 experiences working with community advisory boards: How community member feedback impacted the research. J Clin Transl Sci. 2021;5(1):e117.","journal-title":"J Clin Transl Sci"},{"issue":"1","key":"27526_CR70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/10705421003766685","volume":"18","author":"AJ Silvestre","year":"2010","unstructured":"Silvestre AJ, Quinn SJ, Rinaldo CR. A 22-Year-Old Community Advisory Board: Health Research as an Opportunity for Social Change. J Community Pract. 2010;18(1):58\u201375.","journal-title":"J Community Pract"},{"key":"27526_CR71","doi-asserted-by":"publisher","first-page":"100206","DOI":"10.1016\/j.chbr.2022.100206","volume":"7","author":"MJ Wu","year":"2022","unstructured":"Wu MJ, Zhao K, Fils-Aime F. Response rates of online surveys in published research: A meta-analysis. Comput Hum Behav Rep. 2022;7:100206.","journal-title":"Comput Hum Behav Rep"},{"issue":"8","key":"27526_CR72","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/00187267211070769","volume":"75","author":"B Holtom","year":"2022","unstructured":"Holtom B, Baruch Y, Aguinis H, Ballinger A. Survey response rates: Trends and a validity assessment framework. Hum Relat. 2022;75(8):1560\u201384.","journal-title":"Hum Relat"},{"key":"27526_CR73","doi-asserted-by":"crossref","unstructured":"Allen M, editor. The SAGE encyclopedia of communication research methods: 4. Online-Ausg. Los Angeles, CA: SAGE Publications, Inc. 2017. 1972 p.","DOI":"10.4135\/9781483381411"},{"key":"27526_CR74","unstructured":"Andres L, Designing. & Doing Survey Research [Internet]. 1 Oliver\u2019s Yard, 55 City Road London EC1Y 1SP: SAGE Publications, Ltd; 2012 [cited 2025 Oct 14]. Available from: https:\/\/methods.sagepub.com\/book\/designing-and-doing-survey-research"},{"issue":"3","key":"27526_CR75","doi-asserted-by":"publisher","first-page":"102021","DOI":"10.1016\/j.japh.2024.01.017","volume":"64","author":"G Marley","year":"2024","unstructured":"Marley G, Annis IE, Ostrach B, Egan K, Delamater PL, Bell R, et al. Naloxone Accessibility by Standing Order in North Carolina Community Pharmacies. J Am Pharm Assoc. 2024;64(3):102021.","journal-title":"J Am Pharm Assoc"},{"key":"27526_CR76","doi-asserted-by":"crossref","unstructured":"Dillman DA, Smyth JD, Christian LM. Internet, phone, mail, and mixed-mode surveys: the tailored design method. 4th edition. Hoboken: Wiley; 2014.","DOI":"10.1002\/9781394260645"},{"issue":"4","key":"27526_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/eurjcn\/zvad030","volume":"22","author":"W Shiyab","year":"2023","unstructured":"Shiyab W, Ferguson C, Rolls K, Halcomb E. Solutions to address low response rates in online surveys. Eur J Cardiovasc Nurs. 2023;22(4):441\u20134.","journal-title":"Eur J Cardiovasc Nurs"},{"key":"27526_CR78","doi-asserted-by":"crossref","unstructured":"Marley G, Shubel C, Thorpe C, Annis I, Delamater P, Carpenter D et al. Examining geographic disparities to no-cost naloxone in North Carolina: a cross-sectional survey of no-cost naloxone distributing programs [Unpublished manuscript]. 2025.","DOI":"10.1111\/jrh.70069"},{"issue":"1","key":"27526_CR79","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11524-023-00821-z","volume":"101","author":"ED Nesoff","year":"2024","unstructured":"Nesoff ED, Meisel ZF, Saeed H, Martins SS. Neighborhood and Individual Disparities in Community-Based Naloxone Access for Opioid Overdose Prevention. J Urban Health. 2024;101(1):64\u201374.","journal-title":"J Urban Health"},{"key":"27526_CR80","doi-asserted-by":"publisher","first-page":"109668","DOI":"10.1016\/j.drugalcdep.2022.109668","volume":"241","author":"S Nolen","year":"2022","unstructured":"Nolen S, Zang X, Chatterjee A, Behrends CN, Green TC, Linas BP, et al. Evaluating equity in community-based naloxone access among racial\/ethnic groups in Massachusetts. Drug Alcohol Depend. 2022;241:109668.","journal-title":"Drug Alcohol Depend"},{"key":"27526_CR81","doi-asserted-by":"publisher","first-page":"103435","DOI":"10.1016\/j.drugpo.2021.103435","volume":"98","author":"X Zang","year":"2021","unstructured":"Zang X, Macmadu A, Krieger MS, Behrends CN, Green TC, Morgan JR, et al. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island. Int J Drug Policy. 2021;98:103435.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"27526_CR82","first-page":"268","volume":"12","author":"N Van Quaquebeke","year":"2022","unstructured":"Van Quaquebeke N, Salem M, Van Dijke M, Wenzel R. Conducting organizational survey and experimental research online: From convenient to ambitious in study designs, recruiting, and data quality. Organ Psychol Rev. 2022;12(3):268\u2013305.","journal-title":"Organ Psychol Rev"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-27526-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-27526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:02:34Z","timestamp":1780880554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-27526-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["27526"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-27526-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and determined Not Human Subjects Research by the Institutional Review Board at the University of North Carolina-Chapel Hill. Although the survey was determined Not Human Subjects Research, informed consent was nevertheless obtained through a statement of consent that preceded the survey for all participants. The study procedures adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1816"}}